Discontinued — last reported Q4 '25

Business Segments · Impairment of goodwill

Pharma Solutions — Impairment of goodwill

Year-over-year, this metric declined by 100.0%, from $16.00M to $0.00. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementSegment
CategoryRisk
SignalLower is better
VolatilityVolatile
First reportedQ4 2022
Last reportedQ4 2025Feb 27, 2026

How to read this metric

Any non-zero value is a negative signal, indicating that previous acquisitions or business valuations were overly optimistic.

Detailed definition

Represents a non-cash charge taken when the carrying value of goodwill associated with the Pharma Solutions segment exce...

Peer comparison

Reported by companies following M&A activity when segment performance fails to meet acquisition-time projections.

Metric ID: iff_segment_pharma_solutions_impairment_of_goodwill

Historical Data

13 periods
 Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Value$0.00$0.00$0.00$0.00$0.00$16.00M$16.00M$16.00M$16.00M$0.00$0.00$0.00$0.00
QoQ Change+0.0%+0.0%+0.0%-100.0%
YoY Change-100.0%-100.0%-100.0%-100.0%
Range$0.00$16.00M
Avg YoY Growth-100.0%
Median YoY Growth-100.0%
Current Streak4 quarters decline

Frequently Asked Questions

What is International Flavors & Fragrances's pharma solutions — impairment of goodwill?
International Flavors & Fragrances (IFF) reported pharma solutions — impairment of goodwill of $0.00 in Q4 2025.
How has International Flavors & Fragrances's pharma solutions — impairment of goodwill changed year-over-year?
International Flavors & Fragrances's pharma solutions — impairment of goodwill decreased by 100.0% year-over-year, from $16.00M to $0.00.
What does pharma solutions — impairment of goodwill mean?
A write-down of the value of intangible assets when the segment's business prospects decline.